← Leaderboards
Patricia A Zuk
University Of California Los Angeles
$1,549,517
Attributed
$1,549,517
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $304.9K · FY2007–13$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,549,517 · 2
By mechanism
R01$1,128,558 · 1
R21$420,959 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Kristina I Bostrom$17,274,164
- Linda L. Demer$9,283,629
- Min Lee$5,666,497
- Yin Tintut$5,945,406
- Ichiro Nishimura$3,632,930
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMediatingGrantIn VitroMap Kinase GeneGrowth FactorCellsCraniofacialDefectInnovationHealedAdipose TissueBmp2 GeneAnimal ModelAdhesionsBone EngineeringBone HealingCleaved CellAffectChildBaseHealingBiological ModelsMitogen-Activated Protein Kinase Kinases
Grant awards (6)
Healing of Craniofacial Defects using Adipose-Derived Stem Cells$292,723
R01 · FY2013 · DE · contact PI
Healing of Craniofacial Defects using Adipose-Derived Stem Cells$304,920
R01 · FY2012 · DE · contact PI
Healing of Craniofacial Defects using Adipose-Derived Stem Cells$261,415
R01 · FY2011 · DE · contact PI
Healing of Craniofacial Defects using Adipose-Derived Stem Cells$269,500
R01 · FY2010 · DE · contact PI
Stimulation of ASC Osteogenic Potential In vivo$228,459
R21 · FY2008 · DE · contact PI
Stimulation of ASC Osteogenic Potential In vivo$192,500
R21 · FY2007 · DE · contact PI